Jun 15, 2020
Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin
May 05, 2020
Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Year in June
Apr 07, 2020
Oramed Patent in Canada Allowed for Oral Delivery of Proteins
Apr 01, 2020
Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19
Mar 19, 2020
Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA
Feb 04, 2020
Oramed to Present at BIO CEO & Investor Conference
Jan 28, 2020
Oramed Patent in Europe to be Granted for Oral Delivery of Proteins
Jan 23, 2020
Oramed Elects Dr. Alexander Fleming to Scientific Advisory Board
Jan 21, 2020
Oramed Appoints Dr. Jay Skyler to Scientific Advisory Board
Jan 09, 2020
Oramed Pharmaceuticals Issues Letter to Shareholders
Dec 05, 2019
Oramed Appoints Dr. Arie Mayer to Board of Directors
Dec 02, 2019
Oramed to Present a Scientific Poster at International Diabetes Federation Congress
Nov 21, 2019
Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technology
Nov 14, 2019
Oramed Pharmaceuticals to Discuss Positive Phase IIb Data at Investor Event and Conference Call on Monday, November 18th
Sep 18, 2019
Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference
Sep 03, 2019
Oramed to Present at Three Upcoming Conferences
Jul 10, 2019
Oramed to Present at World Diabetes Congress
Jul 02, 2019
Oramed Announces Xiaoming Gao Joins Board of Directors
Jun 03, 2019
Oramed to Present at BIO International Convention
Apr 29, 2019
Oramed to Present at ThinkEquity Conference